Nipah Virus Infection
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Escalation, Open-Label Clinical Trial to Evaluate Safety, Tolerability and Immunogenicity of a Nipah Virus (NiV) mRNA Vaccine, mRNA-1215, in Healthy Adults (NCT05398796) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-07-11 |
| A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects (NCT05178901) | Public Health Vaccines LLC | 2022-01-10 |
| Safety and Immunogenicity of a Nipah Virus Vaccine (NCT04199169) | Auro Vaccines LLC | 2020-02-18 |
Track Nipah Virus Infection automatically
Every clearance here is in the API, with alerts when new ones post.